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A European roadmap out of the covid-19 pandemic
Coordination between countries is crucial
Martin McKee professor of European public health
London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Europe has been hit especially hard by the covid-19 pandemic,
with Italy, Spain, and France occupying the top three positions
in the global league table of deaths.1 All EU countries have
imposed measures to contain the spread of the virus, although
these vary considerably. Now, as some countries see death rates
falling, they are looking at how to get back to something
resembling normality, and the European Commission has
published a roadmap to guide them.2 Reassuringly, the roadmap
places epidemiology in the driving seat.
Key elements
The roadmap has three key elements. First, no country should
consider lifting restrictions until it is certain that the disease is
under control. This will pose a challenge for some, as it
presupposes that national authorities have accurate and timely
information on cases and deaths. As the United Kingdom’s
experience shows, this can be difficult. The importance of this
information cannot be overstated. Measures taken must be
judged against their ability to keep the reproduction number, or
R0, below 1. In other words, each infected person should not
infect more than one other. Second, countries should ensure that
they have sufficient health system capacity, especially to provide
intensive care, given the risk of a second wave of infections.
Fortunately, there have been many examples of countries with
spare capacity, such as Germany, offering care to patients from
other countries that have been hit especially hard.3 Third, there
must be sufficient capacity for large scale testing and
monitoring, linked to the ability to track and trace contacts of
those infected. This too will be challenging for some and will
necessitate bringing additional laboratories on board.
The roadmap emphasises the importance of coordination after
the decision to lift restrictions has been made. This is especially
important in border areas. In the twin towns of Nova Gorica
and Gorizia, for example, the Italian-Slovenian border divides
the main square, and it would be bizarre to have different
policies on either side. Although not stated in the commission’s
document, the special status of Northern Ireland after Brexit
will require similar measures across the Irish border. So, the
European Commission has called on governments to notify their
neighbours, and the EU, when they propose loosening controls.
What the roadmap does not do is prescribe what measures should
be taken. These are the responsibility of national governments.
It does, however, emphasise that whatever decisions are taken
should be accompanied by a robust system of reporting and
contact tracing, expanded testing capacity, strengthened health
systems that are adequate to cope with any resurgence of
infection after restrictions are lifted, improved personal
protection, and progress in developing new treatments. All of
these measures should be harmonised, making it possible to
exchange information. Ultimately, however, the European
Commission recognises that the threat will be lifted only when
there is a safe and effective vaccine.
Principles
The roadmap proposes principles to underpin any loosening.
First, change should be gradual, allowing enough time to
determine any impact. Second, general measures should be
replaced with progressively more specific ones; for example,
continuing to protect vulnerable people for longer. Third, when
border controls are lifted, there should be careful coordination,
paying particular attention to the situation facing those who live
in border areas. Fourth, economic activity should be phased in;
for example, by allowing those who can work at home to
continue to do so for longer. Fifth, the risks of transmission in
different gatherings, such as sports activities, cafes, or schools,
should be considered carefully. Sixth, measures such as
enhanced hygiene and social distancing should continue. Lastly,
again, there should be careful monitoring.
Finally, the roadmap looks to the future. In his speech to the
French people on 13 April, President Macron said: “In this crisis
there is a chance . . . to build another project.”4 This vision is
echoed in the call to revitalise the economy, returning to a path
of sustainable growth and a greener society, supported by a
major recovery programme, accompanied by a package of
measures including research on vaccines and treatments and
international cooperation.
The initial European response to covid-19 was fragmented and
poorly coordinated. The European Commission’s president,
who trained as a public health physician, has said that Europe
owes Italy an apology for failing to respond adequately.5 But
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the commission’s powers are limited. Covid-19 is a reminder
that there is little point adopting national measures against a
virus that crosses borders with ease. A stronger Europe, with
enhanced powers in health, will be an essential barricade against
the next pandemic.6 The recovery will take a very long time,
but at least the roadmap provides a way forward.
The UK is, of course, now outside the EU and initially declined
an invitation to join the joint procurement initiative.7 At some
stage it will have to develop its own roadmap. Neil Ferguson,
epidemiologist and professor of mathematical biology who
advises the British government, has said that there is “little
leeway” to relax measures without “something . . . in their
place,” such as testing and contact tracing.8 Given the limited
progress so far, this seems a long way off. When the plan finally
emerges, it will very likely look much like what the EU has
produced already. We can only hope that it avoids what has
become the norm over the past four years, whereby the EU
publishes detailed proposals while the corresponding British
documents, lacking substance, have to be prised from the hands
of ministers. Maybe, given the urgency involved, this time we
could borrow some ideas from our neighbours.
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